baber/WOPTO huggingface dataset:
Patent DK-209385-D0 (DK)
Inventor: ERNST RICHARD JOHN
IPC: F16B13/13
Filed: 1985-05-10
Abstract: Athreaded insert (10) for a drywall (42) has an externally threaded portion (13) and an unthreaded drilling portion (15) of generally equal lengths. The insert (10) is adapted to be installed in a single step with the use of a hand powered screwdriver. A low profile flange (29) at the upper end spaced a distance from threads (17) allows the insert to be installed flush with the surface of the drywall (42). The drilling portion (19) can be deflected laterally upon the insertion of a screw (50) allowing the use of a single moderate length screw (50) for attaching articles of various thicknesses. The insert may be moulded from zinc (Figure 1) or plastic material (Figure 7). The insert eliminates the need to pre-drill a hole in the dry wall (42) with a separate tool.
Patent DK-210386-D0 (DK)
Inventor: BOWSKY BENJAMIN
IPC: H02K5/22
Filed: 1986-05-07
Abstract: A hermetic terminal assembly wherein a radially extending flange (21) on a current conducting pin (17) that extends through a hole (11) defined by a cover member (2) adapted to be secured to an opening in a motor housing is surrounded by an electrically insulating sleeve (23) with the inner axial extremity (27) of the sleeve (23) extending at an axial location relative the pin (17) substantially beyond the inner face (28) of the radially extending flange (21) to provide an extended tortuous path between the flange (21) on the pin (17) and the cover member (2), the pin (17) having an aperture (36) extending therein on the inner end thereof within the compass of the sleeve (23), adjacent the inner face (28) of the flange (21) to provide a fuse-like area.
Patent DK-529388-D0 (DK)
Inventor: LIEDEK EGON
IPC: C07D211/62
Filed: 1988-09-23
Abstract: Zinc salts, lead salts and/or calcium salts of carboxylic acids of the formula 
<IMAGE>
 in which A represents a radical of the formula 
<IMAGE>
 Y represents -CO- or -SO2-,
 X<1> represents C1- to C8-alkyl, C1- to C8-alkoxy or halogen,
 X<2> represents hydrogen, C1- to C8-alkyl or halogen,
 X<3> represents hydrogen, nitro or halogen,
 m represents 1 or 2 and
 n represents 1 or 2, it also being possible for X<1> to be hydrogen if A is a radical of the formula (III) or X<3> is nitro or m is 2,
 in particular the basic salts of (I), are suitable as anticorrosives for coating systems.
Patent DK-648588-D0 (DK)
Inventor: PASSCHIER BOB
IPC: A22B5/00
Filed: 1988-11-21
Abstract: PCT No. PCT/NL88/00011 Sec. 371 Date Nov. 23, 1988 Sec. 102(e) Date Nov. 23, 1988 PCT Filed Mar. 22, 1988 PCT Pub. No. WO88/07329 PCT Pub. Date Oct. 6, 1988.A continuous process for recovering meat from a plurality of carcase sections in particular severed animal heads (11) is provided, which comprises mounting the parts on a conveyor (1), advancing them past a number of work stations, at each of which either a manual operator (A-T) or an automatic tool partially dissects the carcase part (11), and recovering the separated meat. Apparatus for performing the process is also provided, comprising a powered conveyor (1), means for securing carcase parts thereon, and at least one automatic tool which acts on the carcase parts, as they pass, by washing, scrubbing, incising, splitting, scraping, tearing, cutting or like procedures. The process divides the meat recovery process into several steps carried out in sequence along the conveyor (1). The process is more hygienic, less labour-intensive, and considerably more productive than conventional procedures.
Patent HU-912918-D0 (HU)
Title: Aryl-fusioned and heteroaryl-fusioned 2,4-diazepine and 2,4-diazocine anti-arrhythmia agents
Inventor: JOHNSON ROBERT ED
IPC: A61K31/34
Filed: 1991-09-10
Abstract: Aryl-fused- and hetaryl-fused-2,4-diazepines of formula XXXVI, benzodiazocines of formula XXX, benzodiazepines of formula II <CHEM> delta -aminoamides of formula III and aryldimethanamines of formula XXXVII <CHEM>  wherein   A   is an aryl, alicyclic or or hetaryl ring; R<1>   is hydrogen, alkyl, aryl or hetaryl; R<2>   is hydrogen, alkyl, substituted alkyl, or aryl; R<3>   is hydrogen, alkyl, aryl, aralkyl, hetaryl or heteroatom substituted alkyl or aralkyl; R<4>   is hydrogen, alkyl or substituted alkyl; R<5>   is hydrogen, alkyl, aryl or hetaryl; R<6>   is hydrogen, alkyl, alkoxy, nitro, alkylsulfonamido, halogen or a fused benzene ring; R<9>   is hydrogen, alkyl, substituted alkyl or aralkyl; and R<1><0>   is hydrogen, alkyl, substituted alkyl, aryl or  hetaryl. This invention further relates to processes for the preparation of, pharmaceutical compositions containing, and methods of treating cardiac arrhythmia with the compounds of formulae XXXVI, XXX, II, III, and XXXVII.
Patent HU-903493-D0 (HU)
Title: Combustion chamber for gas turbine
Inventor: KELLER JACOB
IPC: F23R3/00
Filed: 1990-06-05
Abstract: In a combustion chamber (A) having the shape of an annular combustion chamber, a series of large and small premix burners (B, C) is arranged along the annular front wall (10). The large premix burners (B), which are the main burners of the combustion chamber (A), and the small premix burners (C), which are the pilot burners of the combustion chamber (A), follow each other in alternating sequence and regularly along the front wall (10), where they also open into the combustion space of the combustion chamber (A). A plurality of air nozzles (D) are positioned between the large premix burners (B) and the small premix burners (C), their injection being directed into the combustion space of the combustion chamber (A). <IMAGE>
Patent NO-871062-D0 (NO)
Inventor: GEISER MARTIN
IPC: A01N63/50
Filed: 1987-03-13
Abstract: The present invention is directed to a method for producing an insecticidal proteinaceous substance including the discovery and identification of the entire DNA sequence coding for the insecticidal protein MGE 1 of said proteinaceous substance, to said proteinaceous substance, to a DNA fragment characterized by the nucleotide sequence given in table 2, said fragment coding for the protein MGE 1, to the protein MGE 1 itself, to a DNA fragment originating from Bacillus thuringiensis var.kurstaki from Hpal (O) to Pstl (4355) coding for an insecticidal proteinaceous substance including truncated portions thereof, said truncated DNA portions being subject to the proviso that insecticidal activity has not been lost, to the method of constructing cloning vehicles and expression vehicles comprising the DNA fragment given in table 2 and also to said vehicles themselves.
Patent NO-880719-D0 (NO)
Inventor: SENOO MASAHARU
IPC: C07K16/22
Filed: 1988-02-18
Abstract: A mutein of basic fibroblast growth factors (bFGF) possesses fibroblast growth promoting activity, growth stimulating activity of capillary endothelial cells and angiogenic activity, has high stability and is low toxicity. And therefore, the present mutein is advantageously used as a healing accelerator for burns etc., a therapeutic drug for thrombosis etc., and a cell cultivation promoter.
Patent NO-882913-D0 (NO)
Inventor: HOFMANN HANS
IPC: B22F7/00
Filed: 1988-06-30
Abstract: An electrical contact to a porous metal layer forming an anode of a diaphragm cell in a stack of such cells, is established by sintering a plurality of metal platelets into the porous metal layer. Preferably, the sintering-in of the platelets takes place simultaneously with the sintering of the porous metal layer. Each platelet is provided with an electrical contact metal pin extending out of the porous metal layer.
Patent NO-893988-D0 (NO)
Inventor: KENNEDY CHRISTOPHER ROBIN
IPC: C04B41/88
Filed: 1989-10-05
Abstract: The present invention relates to a novel method for forming metal matrix composite bodies and novel products produced by the method. Particularly, a permeable mass of filler material or a preform (1) has included therein at least some matrix metal powder. Moreover, an infiltration enhancer and/or an infiltration enhancer precursor and/or an infiltrating atmosphere are in communication with the filler material or a preform (1), at least at some point during the process, which permits molten matrix metal to spontaneously infiltrate the filler material or preform (1). The presence of powdered matrix metal in the preform (1) or filler material reduces the relative volume fraction of filler material to matrix metal.
Patent NO-895196-D0 (NO)
Inventor: HONORE TAGE
IPC: A61P25/28
Filed: 1989-12-21
Abstract: Heterocyclic dihydroxyquinoxaline compounds having the formula <CHEM>  wherein R<1> is hydroxy, alkoxy, aryloxy, aralkyloxy, cycloalkylalkoxy, cycloalkoxy, or acyloxy; R<5> and R<6> together form a further fused ring, which is substituted with hydrogen, halogen or CN, and R<7> and R<8> independently are hydrogen, NO2, halogen, CN, SO2NR min R min , SO2R min , CF3, or OR min , wherein R min  is hydrogen or C1-4-alkyl; or R<7> and R<8> together form a further fused ring, which is substituted with hydrogen, halogen or CN, and R<5> and R<6> independently are hydrogen, NO2, halogen, CN, SO2NR min R min , SO2R min , CF3, or OR min , wherein R min  is hydrogen or C1-4-alkyl. The invention also relates to a method of preparing the compounds, pharmaceutical compositions thereof, and their use. The compounds are useful in the treatment of indications caused by hyperactivity of the excitatory neurotransmitters, particularly the quisqualate receptors, and especially as neuroleptics.
Patent NO-903914-D0 (NO)
Inventor: TAMBURINI BRUNO
IPC: C07F/
Filed: 1990-09-07
Abstract: Compounds of the general formula (I) <CHEM>  in which:-  R1 represents a hydroxyl protecting group; and R2 represents a hydrogen or halogen atom, an azido group, a C1-3 alkyl group, a group (CH2)mOR3 wherein m is zero or one and R3 represents a hydrogen atom or a hydroxyl protecting group, an azidoethoxy group, a protected hydroxyethoxy group or a group XR4 in which X is an oxygen atom or the group S(O)n in which n is zero, 1 or 2 and R4 represents a C1-5alkyl, C3-7 cycloalkyl or phenyl group or when X is oxygen or sulphur then R4 may also represent the group AlkNR5R6 in which Alk represents a C2-6 straight or branched alkylene chain and R5 and R6 independently represent a hydrogen atom or C1-4alkyl group or R5 and R6 together with the nitrogen atom to which they are attached form a pyrrolidino or piperidino ring or the group NR5R6 represents a protected amino group, or R2 represents the group (CH2)mNR7R8 in which m is zero or 1 and R7 and R8 independently represent a hydrogen atom or a C1-4alkyl group or NR7R8 represents a protected amino group, or R2 and the carbon atom to which it is attached represent a keto group or a ketal derivative thereof; and acid addition salts of such compounds containing basic centres.
Patent NO-913719-D0 (NO)
Inventor: REAM RONALD L
IPC: B65H35/00
Filed: 1991-09-20
Abstract: There is disclosed a package and dispenser for a rolled, tape-like confectionery product. This dispenser includes a housing means which has top, bottom and side wall means. There is an opening in the side wall means adapted to allow an end of the confectionery product to pass through. The dispenser also includes a hinged means with a hinged end located on one side of the opening. Cutting means are provided on the other side of the opening for contacting and cutting the confectionery product. Locking means are also provided for locking the hinged means in a closed position covering the opening. <IMAGE>
Patent NO-925034-D0 (NO)
Inventor: SAGE JEAN-MARC
IPC: C08G69/36
Filed: 1992-12-29
Abstract: A process for the manufacture of polyamides consisting essentially of the stages of: (i) reacting 10 to 90% by weight of the aliphatic and/or cycloaliphatic and/or aromatic-aliphatic diamines (c) with a lactam and/or corresponding amino acid (a) or the substantially stoichiometric combination of one or more aliphatic diamine(s) and of one or more dicarboxylic aliphatic acid(s) and with the aromatic diacid (b); and (ii) reacting the remainder of the aliphatic and/or cycloaliphatic and/or aromatic-aliphatic diamine (c) with the oligomer produced in stage (i) in one or more substages.
Patent NO-930636-D0 (NO)
Inventor: PAULITSCHKE WERNER
IPC: B65D85/07
Filed: 1993-02-23
Abstract: There exist devices for wrapping a packaging unit (14) of mineral wool plates (15) or a mineral wool roll that have a conveyor (1, 2) for the packaging unit, a foil roll (3) spaced above and a foil roll (4) spaced below the conveyor (1, 2), as well as a welding beam (10) and a stop beam (13) movable towards each other in such a way that they clamp between them the ends of the wrap (26) and weld them together. In addition, a cutter cuts the transversal weld (7) thus produced and welds together the ends of the wrap on the one hand and the ends (5, 6) of the foils that can be drawn from the foil rolls (3, 4). Such packaging units are extremely bulky and difficult to handle. In order to obtain a device capable of producing such a wrap, so that the packaging units can be easily handled, the welding beam (10) and the stop beam (13) are so wide, seen in the direction (16) of transport of the packaging unit (14), whereas the welding beam (10) is provided with at least two spaced apart heating zones (18, 19), that a carrying handle (23) is formed at the periphery of the wrap (26).
Patent NO-931287-D0 (NO)
Inventor: BREIPOHL GERHARD
IPC: A61K38/08
Filed: 1993-04-02
Abstract: Peptides of the formula I  Z - P - A - B - C - E - F - K - (D)Q - G- M- F' - I (I),  in which   Z is optionally substituted (cyclo)alk(ano)yl(sulphonyl), (C1-C8)-alkoxycarbonyl, (hetero)ar(o)yl(sulphonyl), carbamoyl,   P is a direct linkage or a radical II  -NR<2>-(U)-CO- (II> in which   R<2> is H, methyl or a urethane protective group,   U is (cyclo)(aryl)alkylidene, (hetero)arylidene or (CHR<3>)n,   R<3> is hydrogen, (cyclo)alkyl, (hetero)aryl, or in which R<2> and R<3> form, together with the atoms carrying them, a ring system;   A is defined as P;   B is a basic amino acid in the L or D configuration,   C is a compound of the formula IIIa or IIIb  G'-G'-Gly (IIIa> G'-NH-(CH2)p-CO (IIIb> in which p is 2 to 8 and   G' are, independently of one another, a radical of the formula IV -NR<4>-CHR<5>-CO- (IV> in which R<4> and R<5> form, together with the atoms carrying them, a heterocyclic ring system; E is the residue of a neutral, acid or basic, aliphatic or alicyclic-aliphatic amino acid; F are, independently of one another, the radical of a neutral, acid or basic, aliphatic or aromatic amino acid, or a direct linkage; (D)Q is D-Tic, D-Phe, D-Dic, D-Thi or D-Nal, or a radical of the formula (V) <IMAGE> in which X is O, S or a direct linkage, and R is H, (cyclo)alkyl or aryl(alkyl),   G is defined as G' above or is a direct linkage; F' is defined as F, is a radical -NH-(CH2)q- with q = 2 to 8 or, if G is not a direct linkage, can be a direct linkage, and   I is -OH, -NH2 or NHC2H5; K is the radical -NH-(CH2)x-CO- with x = 1-4 or is a direct linkage, and   M is defined as F  and their physiologically tolerated salts are described. They have excellent bradykinin-antagonistic action. They are obtained by reacting a fragment with a C-terminal free carboxyl group or its activated derivative with an appropriate fragment with an N-terminal free amino group, or by assembling the peptide stepwise, eliminating one or more protective groups temporarily introduced where appropriate to protect other functionalities in the compound obtained in this way, and converting the compounds of the formula I obtained in this way where appropriate into their physiologically tolerated salt.
Patent NO-941035-D0 (NO)
Inventor: BACQUE ERIC
IPC: C07D471/04
Filed: 1994-03-22
Abstract: New 1,8-benzo[b]naphthyridine derivative of general formula: <IMAGE> in which R is H or a hydroxyl, amino or alkylamino radical, the alkylamino radical optionally being substituted with amino or hydroxyl, or R is dialkylamino in which the alkyl parts may form, with the nitrogen atom, a 5- or 6-membered heterocycle optionally containing another heteroatom chosen from nitrogen, oxygen or sulphur, or R is cycloalkylamino (3 to 6C), or an alkanoylamino, N-alkyl-N-alkanoylamino or aminoalkylphenylamino radical, R1 and R2, which are identical or different, are in position 2 and 3 and represent H, alkyl, alkenyl (2 to 4C), phenyl or substituted phenyl, or else R1 and R2 are in position 2 and represent alkyl, R3 is H or alkyl, fluoroalkyl, carboxyalkyl, cycloalkyl containing 3 to 6 carbon atoms, fluorophenyl, difluorophenyl, alkyloxy or alkylamino, and R4 is H or F, the alkyl and alkanoyl (1 to 4C) radicals being straight or branched, in its stereoisomeric forms or their mixtures as well as its salts and its hydrated forms. These new derivatives are useful as antimicrobial agents.
Patent NO-951527-D0 (NO)
Inventor: KWAN HENRY K
IPC: A61P11/00
Filed: 1995-04-21
Abstract: A film-coated extended release oral dosage composition containing the nasal decongestant pseudoephedrine sulfate in a unique polymer matrix core and a film-coating on such core containing the non-sedating antihistamine, loratadine, and use of the said composition for treating patients showing the signs and symptoms associated with upper respiratory diseases and nasal congestion are disclosed.
Patent NO-951631-D0 (NO)
Inventor: CHENARD BERTRAND LEO
IPC: C07D401/06
Filed: 1995-04-28
Abstract: PCT No. PCT/US93/06827 Sec. 371 Date Apr. 25, 1995 Sec. 102(e) Date Apr. 25, 1995 PCT Filed Jul. 23, 1993 PCT Pub. No. WO94/10166 PCT Pub. Date May 11, 1994The present invention is directed to compounds of formula (I), and the pharmaceutically acceptable acid addition salts thereof, wherein R is selected from the group consisting of F,-CF3, -OCH3, -O(C1)alkyl substituted with 1 to 3 fluoro atoms. -O(C2) substituted with 1 to 5 fluoro atoms, and -O(C3)alkyl substituted with 1 to 7 fluoro atoms. The compounds of formula (I) are useful in the treatment of stroke, traumatic brain injury and central nervous system degenerative diseases.
Patent NO-955115-D0 (NO)
Inventor: LINDALL KARL B
IPC: H04B15/04
Filed: 1995-12-15
Abstract: In an electronic apparatus including a reference oscillator and an interfering part that generates an interference signal having a spectral component within a receiver bandwidth, the reference oscillator supplying a reference oscillating signal to the interfering part from which reference oscillating signal the interference signal is derived, amplitude of the interference signal within the receiver bandwidth is reduced by angle modulating the reference oscillating signal with a sinusoidal signal to generate an angle modulated interference signal having a reduced carrier amplitude and modulation sidebands that are outside of the receiver bandwidth. The angle modulated interference signal preferably has a modulation index,  beta , that is close to a solution of the equation J0( beta )=0, where J0 is a Bessel function of the first kind. Angle modulation may alternatively be accomplished by applying direct frequency modulation to the reference oscillator with the sinusoidal signal to generate a modulated reference signal and then applying the modulated reference signal to the interfering part, or by phase modulating the reference oscillating signal with the sinusoidal signal prior to supplying it to the interfering part. Where the interference signal has an interfering spectral component within a measurement bandwidth, the amplitude of the interfering spectral component is reduced by using a deterministic, non-noise modulating signal, such as a sawtooth waveform modulating signal, to angle modulate a clock signal from which the interference signal is derived.
Patent NO-961027-D0 (NO)
Inventor: MCCARTHY JAMES RAY
IPC: C07H19/09
Filed: 1996-03-13
Abstract: The present invention provides novel 5-(1-fluorovinyl)-1H-pyrimidine-2,4-dione derivatives of formula (I) which are useful as antineoplastic agents by themselves or in conjunctive therapy with the antineoplastic agent 5-fluorouracil. In said formula, R1 and R2 are each independently hydrogen, C1-C4 alkyl, or a phenyl group unsubstituted or substituted with from 1 to 3 substituents, wherein each substituent is selected from the group consisting of C1-C4 alkyl and C1-C4 alkoxy; and R3 is hydrogen, ribose, 2'-deoxyribose or arabinose.
Patent NO-962407-D0 (NO)
Inventor: THOMAS WAYNE R
IPC: A61P37/08
Filed: 1996-06-07
Abstract: Isolated nucleic acids encoding an allergen of Dermatophagoides pteronyssinus, Der p III, are disclosed. A cDNA encoding a peptide having a Der p III activity and a predicted molecular weight of about 24,985 daltons is also described. The nucleic acids can be used as probes to detect the presence of Der p III nucleic acid in a sample or for the recombinant production of peptides having an activity of Der p III. Peptides having an activity of Der p III can be used in compositions suitable for pharmaceutical administration or methods of diagnosing sensitivity to house dust mites.
Patent NO-964211-D0 (NO)
Inventor: FUCHS KARL-HEINZ
IPC: B05B11/00
Filed: 1996-10-04
Abstract: A discharge apparatus for flowable media, comprising: a basic body, at least partly receiving a pump unit; the pump unit having a pump chamber connectable to a discharge opening via a discharge channel; a pump cylinder and a pump piston bounding the pump chamber; the pump cylinder forming a medium reservoir; the pump piston being displaceably guided in the pump cylinder for discharging all the medium contained in the medium reservoir by a single pump stroke in a pump stroke direction; and, at least one breakable material bridge between the pump unit and the basic body which can be destroyed by an actuating force exerted in the pump stroke direction, whereby the medium is discharged from the apparatus with a predetermined discharging pressure by a predetermined actuating force level and the apparatus is provided with a destroyable tamper-evident closure.
Patent NO-965106-D0 (NO)
Inventor: WINTER ANDREAS
IPC: C08F110/06
Filed: 1996-11-29
Abstract: Copolymer comprises propylene units and a comonomer of ethylene or at least 4C olefin. Copolymer comprises 30-99.5 wt.% propylene units and 0.5-70 wt.% comonomer of ethylene or at least 4C olefin of formula (I): RaCH=CHRb (I) Ra and Rb = H or 1-15C alkyl or form a 4-12C ring with the C atom. An Independent claim is included for a polymer mixture containing at least one such copolymer.
Patent NO-990265-D0 (NO)
Inventor: TANIKAWA KEIZO
IPC: C07D311/70
Filed: 1999-01-21
Abstract: The present invention relates to chroman derivatives of the formula (I): [wherin R1 represents a hydrogen atom, a halogen atom, a C1-6 alkyl group, a C1-6 alkoxy group, a C3-6 alkoxymethyl group, etc., R3 and R4 each independently represent a hydrogen atom, a C1-6 alkyl group, etc., R5 represents a hydroxyl group or a C1-6 alkylcarbonyloxyl group or forms a bond together with R5, R6 represents a hydrogen atom or forms a bond together with R5, R7 and R8 each independently represent a hydrogen atom, a C1-6 alkyl group, a C3-6 cycloalkyl group, a phenyl group, etc. n is 0 or an integer of 1, 2, 3 or 4, W represents a phenyl group, etc., X represents C=O, CH2, SO2, etc., Y represents NR17 (in which R17 represents a hydrogen atom, a C1-4 alkyl group, a phenyl group, etc.), etc., Z does not exist or represents CH2 or NR18 (R18 represents a hydrogen atom, a C1-4 alkyl group, or a phenyl group, etc.)] or their salts.
Patent NO-995225-D0 (NO)
Inventor: HEGGIE WILLIAM
IPC: A61P5/44
Filed: 1999-10-26
Abstract: Mometasone 17- furoate is made by direct esterification of the 17- hydroxyl group of mometasone using 2-furoyl chloride in the presence of a tertiary amine and an inert solvent, without prior protection of the free 11-hydroxy function.